Efficacy and Safety of COMBIGAN® in Korean Patients With Primary Open Angle Glaucoma (POAG) and Normal Tension Glaucoma (NTG)

Study Identifier
CMO-AP-EYE-0428
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Study Details

Medical Condition
  • Glaucoma - Open Angle
  • Glaucoma - Other
  • Study Drug
  • brimonidine tartrate/timolol malate Ophthalmic Solution
  • bimatoprost ophthalmic solution 0.01%
  • Phase
    Phase 4
    Sex
    Female & Male
    Age
    18+ years

    Protocol Summary

    The objective of this study is to evaluate the long-term efficacy and safety of COMBIGAN® (brimonidine tartrate/timolol malate) in patients only using COMBIGAN® (brimonidine tartrate/timolol malate) and also in patients who require additional IOP lowering with LUMIGAN® (bimatoprost) 0.01%.

    Study Locations

    Location
    Status
    Location
    Pusan National University Hospital, Pusan National University School of Medicine
    Busan, Republic of Korea, 49241
    Status
    Not applicable
    Location
    Yeungnam University Hospital, Yeungnam University College of Medicine
    Daegu, Republic of Korea, 42415
    Status
    Not applicable
    Location
    Chungnam National University Hospital, Chungnam National University College of Medicine
    Daejeon, Republic of Korea, 35015
    Status
    Not applicable
    Location
    Chonnam National University Hospital, Chonnam National University Medical School
    Gwangju, Republic of Korea, 61469
    Status
    Not applicable
    Location
    Seoul National University Bundang Hospital, Seoul National University College of Medicine
    Gyeonggi-do, Republic of Korea, 13619
    Status
    Not applicable
    Location
    Seoul National University Hospital, Seoul National University College of Medicine
    Seoul, Republic of Korea, 03080
    Status
    Not applicable
    Showing {first} - {last} of {total} Results